EMEA APPROVAL - PANENZA & HUMENZA CORPORATE ID - VLK ARCHITECTS FDA APPROVAL - BERINET CORPORATE ID - SOLIGENIX EMEA APPROVAL - VICTOZA CONSUMER - AT&T WIRELESS HEALTH CANADA APPROVAL - JANUMET JAPAN APPROVAL - ALLERMIST CORPORATE ID - BREAST CANCER NETWORK OF STRENGTH JAPAN APPROVAL - SENJU PHARMA INN APPROVAL - BLINATUMOMAB EMEA APPROVAL - IRESSA CONSUMER - DUPONT - PIPELINE SOLUTIONS HEALTH CANADA APPROVAL - SIMPONI CONSUMER - MERCEDES BENZ STARMARK FDA APPROVAL - VALTURNA CONSUMER - LANCOME - MAGNIFIQUE JAPAN APPROVAL - GSK EMEA APPROVAL - EXALIEF CONSUMER - DESSERT - CHERIE DOLCE HEALTH CANADA APPROVAL - RASILEZ HCT USAN APPROVAL - CANAGLIFLOZIN CONSUMER - STARBUCKS FRAPPUCCINO FDA APPROVAL - ZIRGAN CLINICAL TRIAL NAME - TRILOGY ACS JAPAN - LUCENTIS JAPAN APPROVAL - GSK CORPORATE ID - DELENEX EMEA APPROVAL - MULTAQ HEALTH CANADA APPROVAL - DORIBAX CONSUMER - IBM RICOH FDA APPROVAL - METOZOLV ODT JAPAN APPROVAL - SANOFI AVENTIS CONSUMER - P&G CHARMIN EMEA APPROVAL - IXIARO CONSUMER - WRIGLEY'S - TWINS JAPAN APPROVAL - APIDRA SOLOSTAR CONSUMER - DOVE - ANTIAGING USAN APPROVAL - ELACYTARABINE DEVICE - BLOOD TEST NAMING - ONDOSE EMEA APPROVAL - OSLIF BREEZHALER JAPAN APPROVAL - SANOFI AVENTIS CORP ID - BAYER NEW BUSINESS FDA APPROVAL - ISTODAX CONSUMER - PEPSI MINI INN APPROVAL - MODITHROMYCIN CLASS NAME - MIRCERA CONSUMER - FRUIT OF THE LOOM JAPAN APPROVAL - TASIGNA JAPAN APPROVAL - SANOFI AVENTIS DIVISION NAMING - STAGE6 FDA APPROVAL - FOLOTYN PRODUCT NAMING - McDONALD'S PREMIUM SALADS EMEA APPROVAL - FOCETRIA CORPORATE ID - DELENEX HEALTH CANADA APPROVAL - ONGLYZA CORPORATE ID - ViiV HEALTHCARE USAN APPROVAL - ROZROLIMUPAB CONSUMER - ACTIBRUSH 360 EMEA APPROVAL - PANDEMRIX CONSUMER - MARS - WORLD OF GRAINS JAPAN APPROVAL - LUCENTIS CONSUMER - GOLDMAN SACHS INN APPROVAL - OCRIPLASMIN RECENT APPROVAL - PURDUE PHARMA RECENT EMEA APPROVAL - WYETH RECENT FDA APPROVAL - NEUROGESX JAPAN APPROVAL - SANOFI AVENTIS

In The News
Preventing Medication Errors – A National Priority ..... Read Article
Brand Institute was invited to FOX BUSINESS to discuss the Drug Name Game..... Watch the Video
View Brand Institute on The Health Issue on CBS Sunday Morning ..... Watch Video

Welcome to Brand Institute

Brand Institute is the world's premier brand identity consultancy. Our brand agency portfolio of services includes brand strategy/architecture, name development, trademark searching and risk assesment, market research, regulatory affairs and design solutions.

Brand Institute is the parent company of Drug Safety Institute (DSI), a subsidiary comprised of former nomenclature safety experts from the Food and Drug Administration (FDA), Health Canada, USAN Council, and World Health Organization (WHO). This skilled and knowledgeable team provides our pharmaceutical and biotechnology clients with name safety and marketing research services, providing the most efficient and proven paths to drug name approval.

Our brand experience extends well beyond the healthcare space, with 15 years of consumer and business to business (B2B) brand success stories. We have a client list of over 1,000 companies and a portfolio of over 1,400 brands, more than any other branding company.

With regional offices strategically located throughout the world, Brand Institute offers the highest level of in-house expertise, industry-defining methodologies, value, accuracy, on time deliverables and uncompromised service. Call the office nearest you today to see why we are Where Great Brands Begin!

 

© 2009 Copyright - Brand Institute, Inc. | Site Map | Employment